Transient and Slight Thrombocytopaenia Induced by Etanercept During Treatment of Psoriatic Arthritis

By Stinco Giuseppe   Piccirillo Fabio   Patrone Pasquale  

Acta Dermato-Venereologica, Vol. 88, Iss. 3, 2008-05 ,pp. : 281-282

Medical Journals Limited

Access to resources Recommend Favorite

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis

By Papp Kim   Ho Vincent   Langley Richard   Lynde Charles   Poulin Yves   Shear Neil   Toole John   Zip Catherine  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 1, 2005-12 ,pp. : 26-32

Springer Publishing Company

Access to resources Recommend Favorite

Rapid Growth of Merkel Cell Carcinoma During Etanercept Treatment of Psoriatic Arthritis: Cause or Coincidence?

By de Giorgi Vincenzo   Benemei Silvia   Grazzini Marta   Lotti Torello   Geppetti Pierangelo  

Acta Dermato-Venereologica, Vol. 91, Iss. 3, 2011-05 ,pp. : 354-355

Medical Journals Limited

Access to resources Recommend Favorite

Treatment of Recalcitrant Dermatomyositis with Efalizumab

By Huber Andrea   Gaffal Evelyn   Bieber Thomas   Tüting Thomas   Wenzel Joerg  

Acta Dermato-Venereologica, Vol. 86, Iss. 3, 2006-05 ,pp. : 254-255

Medical Journals Limited

Access to resources Recommend Favorite

Onset of palmoplantar pustular psoriasis while on adalimumab for psoriatic arthritis: A ‘class effect’ of TNF-α antagonists or simply an anti-psoriatic treatment adverse reaction?

By Rallis Efstathios   Korfitis Chrysovalantis   Stavropoulou Evgenia   Papaconstantis Markos  

Journal of Dermatological Treatment, Vol. 21, Iss. 1, 2010-01 ,pp. : 3-5

Informa Healthcare

Access to resources Recommend Favorite